Please select the option that best describes you:
What are your top takeaways from ASCO GI 2024?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
Answer from: Medical Oncologist at Academic Institution
ALL CTDNA IS NOT CREATED EQUAL (the only way I reconcile the negative findings of COBRA using a tumor-uninformed assay in predicting the efficacy of adjuvant chemo in stage II colon cancer: https://www.cancernetwork.com/view/ctdna-does-not-confer-chemo-efficacy-in-stage-ii-crc-following-surgery&nb...
Sign in or Register to read more